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Etiology 
Cryptosporidiosis results from infection by Cryptosporidium parvum, a coccidian 
parasite. This organism is an obligate intracellular pathogen. 
Geographic Distribution 
Cryptosporidiosis occurs worldwide. 
Transmission 
Transmission is usually by the fecal–oral route but can also occur by aerosols. 
Sporulated oocyts are shed in the feces and are immediately infectious; they may 
survive for 2 to 6 months in a moist environment. Direct transmission between 
animals or humans is common. An estimated 50% of dairy calves shed oocysts; 
calves often spread cryptosporidiosis to each other or to humans. Infections have also 
been documented in 10% of the puppies in at least one shelter; however, transmission 
from household pets to humans is rare and poorly documented. Transmission also 
occurs on fomites and contaminated food or water can result in outbreaks  
Disinfection 
C. parvum is resistant to most disinfectants including a 3% hypochlorite solution. 
Heating to 65°C for 30 minutes, or an18–hour exposure to 5% ammonia, 10% formol 
saline or 3% hydrogen peroxide can reduce infectivity. In the environment, oocysts 
may be killed with a 5% ammonia solution or by desiccation. 
Infections in Humans 
Incubation Period 
Human infections have an incubation period of 1 to 12 days; 7 days is typical. 
Clinical Signs 
In humans, cryptosporidiosis is characterized by profuse, watery diarrhea with 
cramping, abdominal pains, nausea, anorexia, flatulence and malaise. Some 
individuals may also experience vomiting, weight loss, fever or myalgia. The disease 
is usually self–limiting in healthy people but may be chronic, debilitating and severe 
in those who are immunosuppressed (e.g. AIDS patients). Pulmonary or tracheal 
cryptosporidiosis is characterized by coughing, often accompanied by a low–grade 
fever and severe intestinal symptoms. Asymptomatic infections are also seen. 
Communicability 
Yes. Sporulated oocysts are shed in the feces throughout the illness and for 
several weeks afterward. Children wearing diapers often spread the disease in day 
care centers. Caregivers nursing ill persons are also at an increased risk of infection. 
Diagnostic Tests 
Cryptosporidiosis can be diagnosed by finding C. parvum after fecal flotation in 
sucrose or zinc sulfate solutions. Mature oocysts are 4–5µm in diameter and contain 4 
thin, flat, motile sporozoites. The oocysts appear red after acid–fast staining. 
Immunofluorescence can also be used to identify Cryptosporidium in the feces. 
Pulmonary or tracheal cryptosporidiosis is diagnosed in stained biopsy specimens; 
intestinal cryptosporidiosis is occasionally diagnosed this way. 
Treatment and Vaccination 
Other than supportive care, there is no treatment. Vaccines are not available. 
Morbidity and Mortality 
In North America, approximately 2% of the population is infected and 80% has 
been exposed at some time. Worldwide; the prevalence is 1 to 4.5% in developed 
countries and 3 to 20% in developing countries. In healthy people the infection is 
usually self–limiting and resolves after 2 to 4 days; however, episodes of diarrhea 
lasting 1 to 4 weeks have been seen at some day care centers. Lifelong symptomatic  
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infections may develop in immunosuppressed individuals, 
particularly AIDS patients; these infections may be 
debilitating and contribute to death. Estimated infection 
rates in AIDS patients range from 3 to 20% in the United 
States and 50 to 60% in Africa and Haiti. 
Infections in Animals 
Species Affected 
C. parvum is not host specific and can infect all 
mammals. Cryptosporidiosis is common in calves and other 
young ruminants, occurs in pigs, and is rarely seen in dogs, 
cats and horses. Infections are usually seen in neonates. 
Other species of Cryptosporidium can affect birds and 
reptiles 
Incubation Period 
The mean incubation period in calves is approximately 
4 days. 
Clinical Signs 
Cryptosporidiosis mainly occurs in very young 
animals. Among calves, one to three week old animals 
seem to be most susceptible. Clinical signs may include 
anorexia, diarrhea, tenesmus and weight loss. More severe 
disease can occur with concurrent infections. Animals can 
also be colonized without symptoms. 
Communicability 
Yes. Infectious sporulated oocysts are shed in the 
feces. 
Diagnostic Tests 
Cryptosporidiosis can be diagnosed by finding C. 
parvum after fecal flotation in sucrose or zinc sulfate 
solutions. Mature oocysts are 4–5µm in diameter and 
contain 4 thin, flat, motile sporozoites. The oocysts appear 
red after acid–fast staining. Oocysts are not shed 
continuously and repeated sampling may be necessary. 
Cryptosporidiosis can also be diagnosed in stained 
biopsy/necropsy specimens or fresh intestinal scrapings. 
Treatment and Vaccination 
No specific treatment is available; supportive therapy is 
usually effective as the disease tends to be self–limiting. 
Vaccines have not been developed. 
Morbidity and Mortality 
In normal healthy animals, morbidity is high but 
mortality is low. Immunosuppressed and neonatal animals 
are more susceptible to severe disease. 
Post Mortem Lesions      Click to view images 
The typical gross lesion is hyperemia in the intestinal 
mucosa, with yellowish intestinal contents. 
Cryptosporidiosis can affect most of the intestinal tract in 
calves but the most severe lesions are usually found in the 
distal small intestine. In horses, infection is found only in 
the small intestine. On microscopic examination, mild to 
severe villous atrophy can be seen, and spherical organisms 
may be noted in the brush border. 
Internet Resources 
Animal Health Australia. The National Animal Health  
Information System (NAHIS) 
http://www.brs.gov.au/usr–bin/aphb/ahsq?dislist=alpha 
Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov/ncidod/dpd/parasites/cryptosporidi
osis/crypto_source_of_infect.htm 
Material Safety Data Sheets–Canadian Laboratory Center 
for Disease Control  
http://www.hc–sc.gc.ca/pphb–dgspsp/msds–
ftss/index.html#menu 
The Merck Manual 
http://www.merck.com/pubs/mmanual/ 
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp 
U.S. FDA Foodborne Pathogenic Microorganisms and 
Natural Toxins Handbook (Bad Bug Book) 
http://vm.cfsan.fda.gov/~mow/intro.html 
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